New target isolated for leukemia drug development

Protein plays previously unknown role in AML development

2014-02-11

(Press-News.org) SAN ANTONIO (February 11, 2014) – There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher has pinpointed a protein that could play a key, previously unknown role in the development of pediatric AML — promising new information in the quest to treat and cure childhood leukemias.

AML starts at the point when cells mature into different kinds of blood cells. In AML, the cancerous cells grow and proliferate in an abnormal way, and they fail to develop, or differentiate, into normal functioning white blood cells. Also, high levels of a protein called WTAP contribute to abnormal cell behavior, observed Sanjay Bansal, Ph.D., a researcher at the Greehey Children's Cancer Research Center at The University of Texas Health Science Center at San Antonio.

Dr. Bansal and his team, working with leukemia cells, used a laboratory technique to "knock down" WTAP expression in AML cells. What resulted was, in the research world, a resounding success.

"Knocking down this protein, WTAP, greatly suppressed proliferation and induced differentiation," said Hima Bansal, Ph.D., senior research associate at the Health Science Center and lead author of the paper. "It took care of both problems."

But they needed to understand how WTAP levels get so high in AML in the first place.

The researchers turned to another protein called Hsp90, a so-called "molecular chaperone" that helps stabilize more than 200 other proteins, known as Hsp90 "clients".

"When we suppressed Hsp90, we reduced WTAP," Dr. Bansal said. "So we have discovered two things: WTAP's role in AML and the mechanism underlying its overexpression."

Many of Hsp90's other client proteins are known targets in oncology, and "WTAP joins the list," Dr. Bansal said.

This discovery could open the door to more effective therapies for children and adults with newly diagnosed AML or for patients who have failed currently available treatments.

INFORMATION: For current news from the UT Health Science Center, please visit our news release website or follow us on Twitter @uthscsa.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit http://www.ctrc.net.

ELSE PRESS RELEASES FROM THIS DATE:

No clowning around: Juggling sheds light on how we run

2014-02-11

Juggling may seem like mere entertainment, but a study led by Johns Hopkins engineers used this circus skill to gather critical clues about how vision and the sense of touch help control the way humans and animals move their limbs in a repetitive way, such as in running. The findings eventually may aid in the treatment of people with neurological diseases and could lead to prosthetic limbs and robots that move more efficiently. The study was published online recently by the Journal of Neurophysiology and will be the cover article in the journal's March 2014 print edition. In ...

EU rules are denying children latest cancer drugs

2014-02-11

Children with cancer are being denied new, potentially life-saving drugs, because EU rules are allowing companies to trial some drugs only in adults, leading cancer experts warn today. Changes to how EU rules are implemented could allow children access to a goldmine of potential cancer drugs which have currently only been tested in adults – by making it more difficult for pharma companies to avoid testing them in under-18s too. Under the current system, pharma companies often gain exemptions from carrying out expensive testing of cancer drugs in patients under the age ...

Heart attack research discovers new treatment target

2014-02-11

New Orleans, LA – Research led by David Lefer, PhD, Professor and Director of the Cardiovascular Center of Excellence at LSU Health Sciences Center New Orleans School of Medicine, demonstrates for the first time cross-talk between two protective signaling molecules during a heart attack. By providing new and important information about the mechanisms involved in heart attacks and organ transplantation, the research identifies a potential new treatment target for heart disease. The paper will be published in Proceedings of the National Academy of Sciences (PNAS) Online Early ...

Point-of-care ultrasound for suspected appendicitis in kids proves accurate

2014-02-11

New York, NY – Using portable ultrasound as a first-line imaging study in kids with suspected appendicitis helps reduce emergency room length of stay and reduces the need for CT scans, according to a team of Mount Sinai researchers. Bedside ultrasound, often referred to as point-of-care ultrasonography, has a specificity of about 94%, meaning that it misses few cases, , the Mt. Sinai researchers add. Results from the study are published online February 10 in the peer-reviewed journal Academic Emergency Medicine. "From an institutional perspective, this is the most common ...

ASTRO and SSO issue consensus guideline on margins for breast-conserving surgery with WBI

2014-02-11

Fairfax, Va., February 10, 2014 – The American Society for Radiation Oncology (ASTRO) and the Society of Surgical Oncology (SSO) are pleased to announce the publication of the consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. The guideline document represents an intensive collaboration among experts in the radiation oncology and surgical oncology fields, led by Meena S. Moran, MD, associate professor of the Department of Therapeutic Radiology at Yale School of Medicine in New Haven, Conn., ...

Maps show expected redistribution of global species due to climate change

2014-02-11

As climate change unfolds over the next century, plants and animals will need to adapt or shift locations to follow their ideal climate. A new study provides an innovative global map of where species are likely to succeed or fail in keeping up with a changing climate. The findings appear in the science journal Nature. As part of a UC Santa Barbara National Center for Ecological Analysis and Synthesis (NCEAS) working group, 18 international researchers analyzed 50 years of sea surface and land temperature data (1960-2009). They also projected temperature changes under ...

Obese children more likely to have complex elbow fractures and further complications

2014-02-11

ROSEMONT, Ill.─Pediatric obesity is currently an epidemic, with the prevalence having quadruped over the last 25 years. Children diagnosed with obesity can be at risk for various long-term health issues and may be putting their musculoskeletal system at risk. According to new research in the February issue of the Journal of Bone and Joint Surgery (JBJS), obese children who sustain a supracondylar humeral (above the elbow) fracture can be expected to have more complex fractures and experience more postoperative complications than children of a normal weight. "These ...

Giant mass extinction may have been quicker than previously thought

2014-02-11

The largest mass extinction in the history of animal life occurred some 252 million years ago, wiping out more than 96 percent of marine species and 70 percent of life on land — including the largest insects known to have inhabited the Earth. Multiple theories have aimed to explain the cause of what's now known as the end-Permian extinction, including an asteroid impact, massive volcanic eruptions, or a cataclysmic cascade of environmental events. But pinpointing the cause of the extinction requires better measurements of how long the extinction period lasted. Now researchers ...

High pollutant levels in Guánica Bay 'represent serious toxic threat' to corals

2014-02-11

The pollutants measured in the sediments of Guánica Bay, Puerto Rico, in a new NOAA study were among the highest concentrations of PCBs, chlordane, chromium and nickel ever measured in the history of NOAA's National Status & Trends, a nationwide contaminant monitoring program that began in 1986. Researchers from the National Ocean Service's National Centers for Coastal Ocean Science (NCCOS) studied the reef's ecology to help establish baseline conditions that coastal managers can use to measure changes resulting from new efforts to manage pollution. Among the items studied ...

Design prototype chip makes possible a fully implantable cochlear implant

2014-02-11

BOSTON (Feb. 10, 2014) — Researchers from Massachusetts Eye and Ear, Harvard Medical School, and Massachusetts Institute of Technology (MIT) have designed a prototype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. They will present their findings on Feb. 11at the IEEE International Solid State Circuits Conference in San Francisco. A cochlear implant is a device that electronically stimulates the auditory nerve to restore hearing in people with profound hearing loss. Conventional cochlear implants are made up of an external unit with ...

New target isolated for leukemia drug development

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: